Gottfries C G
Acta Psychiatr Scand Suppl. 1981;290:353-6. doi: 10.1111/j.1600-0447.1981.tb00739.x.
Depression is often combined with loss of appetite and weight. Treatment with some psychotropic drugs, especially many of the tricyclic antidepressives, causes weight gain. Zimelidine, an antidepressive drug with selective inhibitory effect on the reuptake of 5-hydroxytryptamine (5-HT) causes no weight gain in treated patients. As even weight loss is seen it can be discussed whether the drug has an inhibitory effect on feeding behaviour. This would be theoretical interest as animal experiments show that 5-HT may be an anorectic transmitter. It is also of practical importance as then the embarrassing side effect of weight gain might be avoided in antidepressive treatment.
抑郁症常伴有食欲不振和体重下降。使用某些精神药物进行治疗,尤其是许多三环类抗抑郁药,会导致体重增加。齐美利定是一种对5-羟色胺(5-HT)再摄取具有选择性抑制作用的抗抑郁药,在接受治疗的患者中不会导致体重增加。由于甚至出现了体重减轻的情况,因此可以探讨该药物是否对进食行为有抑制作用。这在理论上具有重要意义,因为动物实验表明5-HT可能是一种厌食递质。这在实际中也很重要,因为这样在抗抑郁治疗中可能避免体重增加这种令人尴尬的副作用。